XML 124 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash flows from operating activities:    
Loss from continuing operations $ (10,063,000) $ (46,357,000)
Adjustments to reconcile loss from continuing operations to net cash used by operating activities:    
Depreciation and amortization 1,136,000 2,647,000
Stock based compensation 268,000
Loss (income) on equity method investment (7,000) 22,000
Gain on investments 572,000 30,790,000
Change in ROU assets 369,000 774,000
Gain on sale of assets (165,000)
Provision for loan losses 815,000 3,757,000
Decrease (increase) in assets:    
Accounts receivable 1,679,000 2,531,000
Inventory (753,000) 4,707,000
Prepaid expenses and other current assets 504,000 592,000
Other assets (42,000) 3,123,000
Increase (decrease) in liabilities:    
Accounts payable (224,000) (3,846,000)
Accrued expenses (529,000) (15,958,000)
ROU liabilities (339,000) (1,052,000)
Other liabilities 1,473,000 (81,000)
Net cash used by operating activities - continuing operations (5,574,000) (18,083,000)
Net cash used by operating activities - held for sale (1,632,000)
Net cash used by operating activities (5,574,000) (19,715,000)
Cash flows from investing activities:    
Purchase of property, plant and equipment (29,000) (496,000)
Purchase of investment (379,000)
Disposal of property, plant and equipment 5,140,000 215,000
Sale of marketable securities 11,330,000
Payments received on notes receivable 4,044,000 2,327,000
Net cash provided by investing activities 8,776,000 13,376,000
Cash flows from financing activities:    
Payments of long-term debt (1,269,000) (5,519,000)
Borrowings of long-term debt 2,171,000 2,601,000
Net cash provided (used) by financing activities 902,000 (2,918,000)
Net increase (decrease) in cash - continuing operations 4,104,000 (7,625,000)
Net increase (decrease) in cash - held for sale (1,632,000)
Cash and cash equivalents at beginning of period 6,615,000 19,290,000
Cash and cash equivalents at end of period $ 10,719,000 $ 10,033,000